Ibrahim Ramy Riad Ahmed — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Ibrahim Ramy Riad Ahmed has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
According to the most recent SEC filing dated 2026-07-06, Ibrahim Ramy Riad Ahmed is listed as President of the PDT BU at Takeda Pharmaceutical Co Ltd. The PDT BU designation indicates a Takeda business unit referenced in the filing. The available SEC context provides limited biographical detail beyond his current role, and there is no publicly disclosed information in the provided data about his education, prior positions, or career history. He is presented as a current executive within Takeda with responsibilities typical of a BU president, including strategic leadership and operational oversight for the unit. There is no indication in the provided context of his death, and no additional personal biographical information is available.
According to the most recent SEC filing dated 2026-07-06, Ibrahim Ramy Riad Ahmed is listed as President of the PDT BU at Takeda Pharmaceutical Co Ltd. The PDT BU designation indicates a Takeda business unit referenced in the filing. The available SEC context provides limited biographical detail beyond his current role, and there is no publicly disclosed information in the prov…
How many SEC Form 4 filings has Ibrahim Ramy Riad Ahmed submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Ibrahim Ramy Riad Ahmed's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
